REG - Celtic PLC - Issue of Equity

CelticAnnouncement

29/06/2018 12:10

RNS Number : 0887T
Celtic PLC
29 June 2018
 


CELTIC PLC
Issued share capital
 
As a result of the conversion of 400 Convertible Preferred Ordinary Shares of 100p each, Celtic PLC's issued share capital as at 28 June 2018 was as follows:
 
93,758,459           Ordinary Shares of 1p each ("Ordinary Shares")                       
12,920,479           Convertible Preferred Ordinary Shares of 100p each ("CPO Shares")
15,927,917           Convertible Cumulative Preference Shares of 60p each ("CCP Shares")
650,358,512        Deferred Shares of 1p each ("Deferred Shares")
 
CCP Shares do not carry voting rights. Deferred Shares are not listed, are not transferable and carry no voting rights or substantive economic rights. 
 
The above figures for Ordinary Shares and CPO Shares may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change in their interest in voting rights under the FCA's Disclosure Guidance and Transparency Rules.
 
Application has been made for the admission of the 832 new Ordinary Shares of 1p each arising from these conversions ("New Ordinary Shares") to trading on AIM. It is expected that dealings in these New Ordinary Shares, which will rank pari passu in all respects with the existing Ordinary Shares of the Company, is expected to commence on 5 July 2018.
 
Enquiries:
 
 



Company
Michael Nicholson, Company Secretary 


 
0141 551 4298




 


 




Canaccord Genuity Limited
Simon Bridges, Nominated Adviser     


 
020 7523 8350



 
                               
 
 
                               
 




This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
IOEFKLFLVQFBBBE